Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 322

    1.

    Key Role of the GITR/GITRLigand Pathway in the Development of Murine Autoimmune Diabetes: A Potential Therapeutic Target.

    You S, Poulton L, Cobbold S, Liu CP, Rosenzweig M, Ringler D, Lee WH, Segovia B, Bach JF, Waldmann H, Chatenoud L.

    PLoS One. 2009 Nov 20;4(11):e7848.PMID: 19936238 [PubMed - in process]Free article

    2.

    Childhood cancer mortality in Europe, 1970-2007.

    Bosetti C, Bertuccio P, Chatenoud L, Negri E, Levi F, La Vecchia C.

    Eur J Cancer. 2009 Oct 7. [Epub ahead of print]PMID: 19818600 [PubMed - as supplied by publisher]Related articles

    3.

    Emergency Medical System response to out-of-hospital cardiac arrest in Milan, Italy.

    Morici N, De Luca G, Lucenteforte E, Chatenoud L, Fontana G, La Vecchia C, Sesana G.

    Eur J Emerg Med. 2009 Sep 4. [Epub ahead of print]PMID: 19738476 [PubMed - as supplied by publisher]Related articles

    4.

    FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis.

    Zuber J, Brodin-Sartorius A, Lapidus N, Patey N, Tosolini M, Candon S, Rabant M, Snanoudj R, Panterne C, Thervet E, Legendre C, Chatenoud L.

    Nephrol Dial Transplant. 2009 Dec;24(12):3847-54. Epub 2009 Sep 3.PMID: 19729462 [PubMed - in process]Related articlesFree article

    5.

    Asthma mortality and long-acting beta2-agonists in five major European countries, 1994-2004.

    Chatenoud L, Malvezzi M, Pitrelli A, La Vecchia C, Bamfi F.

    J Asthma. 2009 Aug;46(6):546-51.PMID: 19657893 [PubMed - indexed for MEDLINE]Related articles

    6.

    Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients.

    Candon S, Thervet E, Lebon P, Suberbielle C, Zuber J, Lima C, Charron D, Legendre C, Chatenoud L.

    Am J Transplant. 2009 Oct;9(10):2346-54. Epub 2009 Jul 28.PMID: 19656126 [PubMed - in process]Related articles

    7.

    Progress towards the clinical use of CD3 monoclonal antibodies in the treatment of autoimmunity.

    Chatenoud L.

    Curr Opin Organ Transplant. 2009 Aug;14(4):351-6. Review.PMID: 19610168 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Increase of CXCL10 serum level in systemic sclerosis interstitial pneumonia]

    Tiev KP, Chatenoud L, Kettaneh A, Tolédano C, Bach JF, Cabane J.

    Rev Med Interne. 2009 Nov;30(11):942-6. Epub 2009 Jul 4. French. PMID: 19577826 [PubMed - in process]Related articles

    9.

    Recent patterns in gastric cancer: a global overview.

    Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, Malvezzi M, La Vecchia C.

    Int J Cancer. 2009 Aug 1;125(3):666-73.PMID: 19382179 [PubMed - indexed for MEDLINE]Related articles

    10.

    Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update.

    Levi F, Chatenoud L, Bertuccio P, Lucchini F, Negri E, La Vecchia C.

    Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):333-50.PMID: 19369880 [PubMed - indexed for MEDLINE]Related articles

    11.

    Registry research in dermatology.

    Naldi L, Chatenoud L.

    Dermatol Clin. 2009 Apr;27(2):185-91, vii. Review.PMID: 19254662 [PubMed - indexed for MEDLINE]Related articles

    12.

    Dietary glycemic load and gastric cancer risk in Italy.

    Bertuccio P, Praud D, Chatenoud L, Lucenteforte E, Bosetti C, Pelucchi C, Rossi M, Negri E, La Vecchia C.

    Br J Cancer. 2009 Feb 10;100(3):558-61.PMID: 19190635 [PubMed - indexed for MEDLINE]Related articles

    13.

    Immunoregulatory pathways controlling progression of autoimmunity in NOD mice.

    You S, Alyanakian MA, Segovia B, Damotte D, Bluestone J, Bach JF, Chatenoud L.

    Ann N Y Acad Sci. 2008 Dec;1150:300-10. Review.PMID: 19120317 [PubMed - indexed for MEDLINE]Related articles

    14.

    CD3 antibodies as unique tools to restore self-tolerance in established autoimmunity their mode of action and clinical application in type 1 diabetes.

    You S, Candon S, Kuhn C, Bach JF, Chatenoud L.

    Adv Immunol. 2008;100:13-37. Review. No abstract available. PMID: 19111162 [PubMed - indexed for MEDLINE]Related articles

    15.

    Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project.

    Naldi L, Addis A, Chimenti S, Giannetti A, Picardo M, Tomino C, Maccarone M, Chatenoud L, Bertuccio P, Caggese E, Cuscito R.

    Dermatology. 2008;217(4):365-73. Epub 2008 Sep 23.PMID: 18810241 [PubMed - indexed for MEDLINE]Related articles

    16.

    Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck.

    Sassi F, Cazzaniga S, Tessari G, Chatenoud L, Reseghetti A, Marchesi L, Girolomoni G, Naldi L.

    Br J Dermatol. 2008 Nov;159(5):1186-91. Epub 2008 Aug 19.PMID: 18717675 [PubMed - indexed for MEDLINE]Related articles

    17.

    Quantitative assessment of antibodies to ribonucleoproteins in primary Sjögren syndrome: correlation with B-cell biomarkers and disease activity.

    Candon S, Gottenberg JE, Bengoufa D, Chatenoud L, Mariette X.

    Ann Rheum Dis. 2009 Jul;68(7):1208-12. Epub 2008 Aug 19.PMID: 18713786 [PubMed - indexed for MEDLINE]Related articles

    18.

    Role of GM-CSF in tolerance induction by mobilized hematopoietic progenitors.

    Kared H, Leforban B, Montandon R, Renand A, Layseca Espinosa E, Chatenoud L, Rosenstein Y, Schneider E, Dy M, Zavala F.

    Blood. 2008 Sep 15;112(6):2575-8. Epub 2008 Jul 10.PMID: 18617637 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The long and winding road towards induction of allograft tolerance in the clinic.

    Chatenoud L.

    Transpl Int. 2008 Aug;21(8):725-7. Epub 2008 Jul 10. No abstract available. PMID: 18573139 [PubMed - indexed for MEDLINE]Related articles

    20.

    Severe neonatal myasthenia due to maternal anti-MuSK antibodies.

    Béhin A, Mayer M, Kassis-Makhoul B, Jugie M, Espil-Taris C, Ferrer X, Chatenoud L, Laforêt P, Eymard B.

    Neuromuscul Disord. 2008 Jun;18(6):443-6. Epub 2008 Apr 22.PMID: 18434154 [PubMed - indexed for MEDLINE]Related articles

    21.

    12-month follow-up after successful infliximab therapy in pediatric crohn disease.

    Wynands J, Belbouab R, Candon S, Talbotec C, Mougenot JF, Chatenoud L, Schmitz J, Cézard JP, Goulet O, Hugot JP, Ruemmele FM.

    J Pediatr Gastroenterol Nutr. 2008 Mar;46(3):293-8.PMID: 18376247 [PubMed - indexed for MEDLINE]Related articles

    22.

    Chemical immunosuppression in islet transplantation--friend or foe?

    Chatenoud L.

    N Engl J Med. 2008 Mar 13;358(11):1192-3. No abstract available. PMID: 18337609 [PubMed - indexed for MEDLINE]Related articles

    23.

    The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.

    Martinuzzi E, Novelli G, Scotto M, Blancou P, Bach JM, Chaillous L, Bruno G, Chatenoud L, van Endert P, Mallone R.

    Diabetes. 2008 May;57(5):1312-20. Epub 2008 Feb 27.PMID: 18305140 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Surgical site infections after elective neurosurgery: a survey of 1747 patients.

    Valentini LG, Casali C, Chatenoud L, Chiaffarino F, Uberti-Foppa C, Broggi G.

    Neurosurgery. 2008 Jan;62(1):88-95; discussion 95-6.PMID: 18300895 [PubMed - indexed for MEDLINE]Related articles

    25.

    Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study.

    Naldi L, Chatenoud L, Belloni A, Peserico A, Balato N, Virgili AR, Bruni PL, Ingordo V, Lo Scocco G, Solaroli C, Schena D, Di Landro A, Pezzarossa E, Arcangeli F, Gianni C, Betti R, Carli P, Farris A, Barabino GF, La Vecchia C, Parazzini F.

    Dermatology. 2008;216(2):125-30; discussion 130-2. Epub 2008 Jan 23.PMID: 18216474 [PubMed - indexed for MEDLINE]Related articles

    26.

    Toward cell-based therapy of type I diabetes.

    Kabelitz D, Geissler EK, Soria B, Schroeder IS, Fändrich F, Chatenoud L.

    Trends Immunol. 2008 Feb;29(2):68-74. Epub 2008 Jan 7.PMID: 18182324 [PubMed - indexed for MEDLINE]Related articles

    27.

    The use of CD3-specific antibodies in autoimmune diabetes: a step toward the induction of immune tolerance in the clinic.

    Chatenoud L.

    Handb Exp Pharmacol. 2008;(181):221-36. Review.PMID: 18071948 [PubMed - indexed for MEDLINE]Related articles

    28.

    [Effects of new smoking regulations in Italy]

    Rodríguez T, Gallus S, Chatenoud L, Zuccaro P, Colombo P, Apolone G, Pacifici R, Garattini S, La Vecchia C.

    Salud Publica Mex. 2006;48 Suppl 1:S137-9. Review. Spanish. PMID: 17684675 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    CD3-specific antibodies: a portal to the treatment of autoimmunity.

    Chatenoud L, Bluestone JA.

    Nat Rev Immunol. 2007 Aug;7(8):622-32. Epub 2007 Jul 20. Review.PMID: 17641665 [PubMed - indexed for MEDLINE]Related articles

    30.

    Reply to 'Alcohol consumption and risk of Hodgkin's lymphoma and multiple myeloma: a multicentre case-control study' by Gorini et al.

    Deandrea S, Bertuccio P, Chatenoud L, Franceschi S, Serraino D, La Vecchia C.

    Ann Oncol. 2007 Jun;18(6):1119-21. No abstract available. PMID: 17586754 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Questioning four preconceived ideas on immunotherapy of clinical type 1 diabetes: lessons from recent CD3 antibody trials.

    Chatenoud L, Bach JF.

    Rev Diabet Stud. 2005 Fall;2(3):116-20. Epub 2005 Nov 10. No abstract available. PMID: 17491686 [PubMed]Related articlesFree article

    32.

    Improving sun-protection behavior among children: results of a cluster-randomized trial in Italian elementary schools. The "SoleSi SoleNo-GISED" Project.

    Naldi L, Chatenoud L, Bertuccio P, Zinetti C, Di Landro A, Scotti L, La Vecchia C; Oncology Cooperative Group of the Italian Group for Epidemiologic Research in Dermatology (GISED).

    J Invest Dermatol. 2007 Aug;127(8):1871-7. Epub 2007 Apr 26.PMID: 17460732 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.

    You S, Leforban B, Garcia C, Bach JF, Bluestone JA, Chatenoud L.

    Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6335-40. Epub 2007 Mar 26.PMID: 17389382 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes.

    Mallone R, Martinuzzi E, Blancou P, Novelli G, Afonso G, Dolz M, Bruno G, Chaillous L, Chatenoud L, Bach JM, van Endert P.

    Diabetes. 2007 Mar;56(3):613-21.PMID: 17327428 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    [One step towards restoration of self-tolerance in human autoimmune diseases]

    Chatenoud L.

    Med Sci (Paris). 2007 Feb;23(2):167-71. Review. French. PMID: 17291426 [PubMed - indexed for MEDLINE]Related articles

    36.

    Testicular cancer mortality in the Americas, 1980-2003.

    Bertuccio P, Malvezzi M, Chatenoud L, Bosetti C, Negri E, Levi F, La Vecchia C.

    Cancer. 2007 Feb 15;109(4):776-9.PMID: 17238185 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Proinsulin: a unique autoantigen triggering autoimmune diabetes.

    You S, Chatenoud L.

    J Clin Invest. 2006 Dec;116(12):3108-10.PMID: 17143326 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    [Thyroiditis and gluten intolerance: extrapancreatic auto-immune diseases associated with type 1 diabetes]

    Faesch S, Jennane F, Izembart I, Chatenoud L, Taupin P, Martin D, Polak M, Robert JJ.

    Arch Pediatr. 2007 Jan;14(1):24-30. Epub 2006 Nov 27. French. PMID: 17125979 [PubMed - indexed for MEDLINE]Related articles

    39.

    Jagged2-expressing hematopoietic progenitors promote regulatory T cell expansion in the periphery through notch signaling.

    Kared H, Adle-Biassette H, Foïs E, Masson A, Bach JF, Chatenoud L, Schneider E, Zavala F.

    Immunity. 2006 Nov;25(5):823-34. Epub 2006 Nov 2.PMID: 17081781 [PubMed - indexed for MEDLINE]Related articles

    40.

    Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice.

    Steffens S, Burger F, Pelli G, Dean Y, Elson G, Kosco-Vilbois M, Chatenoud L, Mach F.

    Circulation. 2006 Oct 31;114(18):1977-84. Epub 2006 Oct 16.PMID: 17043169 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Immune therapies of autoimmune diseases: are we approaching a real cure?

    Chatenoud L.

    Curr Opin Immunol. 2006 Dec;18(6):710-7. Epub 2006 Sep 29. Review.PMID: 17011768 [PubMed - indexed for MEDLINE]Related articles

    42.

    Adaptive human regulatory T cells: myth or reality?

    Chatenoud L, Bach JF.

    J Clin Invest. 2006 Sep;116(9):2325-7.PMID: 16955134 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Protection from autoimmunity: immunological indifference versus T-cell mediated suppression?

    Chatenoud L.

    Eur J Immunol. 2006 Sep;36(9):2296-8. Review.PMID: 16952144 [PubMed - indexed for MEDLINE]Related articles

    44.

    Transforming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes.

    You S, Thieblemont N, Alyanakian MA, Bach JF, Chatenoud L.

    Immunol Rev. 2006 Aug;212:185-202. Review.PMID: 16903915 [PubMed - indexed for MEDLINE]Related articles

    45.

    CD3-specific antibodies as promising tools to aim at immune tolerance in the clinic.

    Chatenoud L.

    Int Rev Immunol. 2006 May-Aug;25(3-4):215-33. Review.PMID: 16818372 [PubMed - indexed for MEDLINE]Related articles

    46.

    [Psoriasis and cancer: more than a chance link]

    Naldi L, Chatenoud L.

    Ann Dermatol Venereol. 2006 Mar;133(3):221-3. Review. French. No abstract available. PMID: 16800169 [PubMed - indexed for MEDLINE]Related articles

    47.

    Prevalence of actinic keratoses and associated factors in a representative sample of the Italian adult population: Results from the Prevalence of Actinic Keratoses Italian Study, 2003-2004.

    Naldi L, Chatenoud L, Piccitto R, Colombo P, Placchesi EB, La Vecchia C; Prevalence of Actinic Keratoses Italian Study (PraKtis) Group.

    Arch Dermatol. 2006 Jun;142(6):722-6.PMID: 16785374 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Weaned from the needle.

    Chatenoud L.

    Nat Med. 2006 Jun;12(6):617-8. No abstract available. PMID: 16761006 [PubMed - indexed for MEDLINE]Related articles

    49.

    Severe human herpesvirus-8 primary infection in a renal transplant patient successfully treated with anti-CD20 monoclonal antibody.

    Thaunat O, Mamzer-Bruneel MF, Agbalika F, Valensi F, Venditto M, Lebbe C, Frances C, Kania R, Chatenoud L, Antoine C, Kaveri S, Kreis H, Morelon E.

    Blood. 2006 Apr 1;107(7):3009-10. No abstract available. PMID: 16554487 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Trends in mortality from coronary heart and cerebrovascular diseases in the Americas: 1970-2000.

    Rodríguez T, Malvezzi M, Chatenoud L, Bosetti C, Levi F, Negri E, La Vecchia C.

    Heart. 2006 Apr;92(4):453-60.PMID: 16537758 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...